RhumbLine Advisers’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194M Sell
616,745
-17,190
-3% -$5.42M 0.15% 101
2026
Q1
$208M Buy
633,935
+6,030
+1% +$2.16M 0.18% 89
2025
Q4
$221M Sell
627,905
-8,127
-1% -$2.96M 0.18% 87
2025
Q3
$235M Buy
636,032
+3,463
+0.5% +$1.34M 0.19% 85
2025
Q2
$250M Sell
632,569
-29,619
-4% -$11.1M 0.21% 78
2025
Q1
$246M Buy
662,188
+9,578
+1% +$3.64M 0.23% 71
2024
Q4
$235M Sell
652,610
-14,261
-2% -$5.28M 0.21% 75
2024
Q3
$241M Sell
666,871
-9,089
-1% -$3.14M 0.22% 73
2024
Q2
$230M Buy
675,960
+9,864
+1% +$3.34M 0.22% 77
2024
Q1
$238M Sell
666,096
-1,932
-0.3% -$650K 0.23% 77
2023
Q4
$200M Sell
668,028
-9,458
-1% -$2.65M 0.21% 87
2023
Q3
$185M Sell
677,486
-4,145
-0.6% -$1.19M 0.21% 85
2023
Q2
$208M Buy
681,631
+3,340
+0.5% +$965K 0.23% 76
2023
Q1
$194M Buy
678,291
+20,069
+3% +$5.32M 0.24% 82
2022
Q4
$161M Buy
658,222
+35,014
+6% +$7.95M 0.22% 88
2022
Q3
$126M Buy
623,208
+9,477
+2% +$1.99M 0.19% 95
2022
Q2
$122M Buy
613,731
+23,669
+4% +$5.56M 0.18% 101
2022
Q1
$158M Buy
590,062
+22,654
+4% +$5.86M 0.2% 88
2021
Q4
$152M Buy
567,408
+11,497
+2% +$3.02M 0.19% 96
2021
Q3
$147M Sell
555,911
-1,941
-0.3% -$519K 0.2% 90
2021
Q2
$145M Sell
557,852
-25,112
-4% -$6.42M 0.19% 95
2021
Q1
$142M Sell
582,964
-71,526
-11% -$17.2M 0.19% 98
2020
Q4
$160M Sell
654,490
-2,487
-0.4% -$563K 0.22% 80
2020
Q3
$137M Sell
656,977
-10,488
-2% -$2.04M 0.21% 87
2020
Q2
$120M Buy
667,465
+22,135
+3% +$4.08M 0.2% 95
2020
Q1
$107M Buy
645,330
+2,619
+0.4% +$512K 0.23% 90
2019
Q4
$135M Sell
642,711
-1,965
-0.3% -$408K 0.23% 83
2019
Q3
$139M Buy
644,676
+22,515
+4% +$4.83M 0.25% 73
2019
Q2
$128M Sell
622,161
-12,235
-2% -$2.34M 0.24% 75
2019
Q1
$125M Buy
634,396
+16,158
+3% +$2.91M 0.24% 78
2018
Q4
$96.9M Sell
618,238
-2,844
-0.5% -$476K 0.21% 90
2018
Q3
$110M Sell
621,082
-23,151
-4% -$3.95M 0.21% 88
2018
Q2
$109M Buy
644,233
+4,231
+0.7% +$712K 0.22% 87
2018
Q1
$103M Sell
640,002
-10,673
-2% -$1.72M 0.22% 92
2017
Q4
$101M Buy
650,675
+979
+0.2% +$149K 0.2% 96
2017
Q3
$92.3M Buy
649,696
+46,914
+8% +$6.73M 0.2% 98
2017
Q2
$83.7M Buy
602,782
+3,093
+0.5% +$424K 0.19% 108
2017
Q1
$78.9M Buy
599,689
+10,012
+2% +$1.26M 0.18% 109
2016
Q4
$70.6M Buy
589,677
+17,164
+3% +$1.97M 0.18% 115
2016
Q3
$66.6M Buy
572,513
+3,638
+0.6% +$424K 0.18% 109
2016
Q2
$68.2M Buy
568,875
+19,873
+4% +$2.22M 0.2% 101
2016
Q1
$58.9M Buy
549,002
+13,837
+3% +$1.36M 0.18% 109
2015
Q4
$49.7M Buy
535,165
+5,738
+1% +$549K 0.16% 126
2015
Q3
$49.8M Buy
529,427
+5,469
+1% +$542K 0.17% 122
2015
Q2
$50.1M Sell
523,958
-77,540
-13% -$7.35M 0.16% 131
2015
Q1
$55.5M Sell
601,498
-9,260
-2% -$862K 0.16% 135
2014
Q4
$57.6M Sell
610,758
-10,939
-2% -$970K 0.17% 130
2014
Q3
$50.2M Sell
621,697
-13,176
-2% -$1.08M 0.15% 144
2014
Q2
$53.5M Sell
634,873
-6,097
-1% -$498K 0.16% 149
2014
Q1
$52.2M Sell
640,970
-19,970
-3% -$1.59M 0.15% 142
2013
Q4
$49.7M Sell
660,940
-22,098
-3% -$1.61M 0.15% 145
2013
Q3
$46.2M Sell
683,038
-6,358
-0.9% -$439K 0.14% 144
2013
Q2
$44.6M Buy
+689,396
New +$45.8M 0.14% 143

Other funds holding SYK

RhumbLine Advisers's SYK Position: Q2 2026 in Review

RhumbLine Advisers reduced its Stryker (SYK) stake by 2.7% in Q2 2026, selling an estimated $5.42M and leaving 616,745 shares worth $194M. The position accounts for 0.15% of the portfolio, ranked #101.

RhumbLine Advisers first reported a position in SYK in Q2 2013 and has held it in 53 quarters since. The position peaked at $250M in Q2 2025. 2,244 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • RhumbLine Advisers held 616,745 shares of Stryker worth $194M as of Q2 2026.
  • RhumbLine Advisers sold 17,190 Stryker shares in Q2 2026, an estimated $5.42M.
  • Stryker made up 0.15% of RhumbLine Advisers's portfolio in Q2 2026, its #101 holding.
  • RhumbLine Advisers first reported a position in Stryker in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Stryker position peaked at $250M in Q2 2025.
  • 2,244 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.